UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Single‐cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy

Cancer communications (London, England), 2020-08, Vol.40 (8), p.329-344

2020

Volltextzugriff (PDF)

The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis

PloS one, 2016-04, Vol.11 (4), p.e0152500-e0152500

2016

Volltextzugriff (PDF)

The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis

PloS one, 2014-12, Vol.9 (12), p.e115103-e115103

2014

Volltextzugriff (PDF)

Stromal cells in tumor microenvironment and breast cancer

Cancer and metastasis reviews, 2013-06, Vol.32 (1-2), p.303-315

2013

Volltextzugriff (PDF)

Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis

Frontiers in oncology, 2021-03, Vol.11, p.629666-629666

2021

Volltextzugriff (PDF)

Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer

Frontiers in immunology, 2023-03, Vol.14, p.1164514-1164514

2023

Volltextzugriff (PDF)

Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24

Nature communications, 2019-09, Vol.10 (1), p.4353-15, Article 4353

2019

Volltextzugriff (PDF)

Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis

Breast cancer research and treatment, 2012-08, Vol.134 (3), p.957-967

2012

Volltextzugriff (PDF)

Comprehensive analysis of the 21-gene recurrence score in invasive ductal breast carcinoma with or without ductal carcinoma in situ component

British journal of cancer, 2021-03, Vol.124 (5), p.975-981

2021

Volltextzugriff (PDF)

A Smartphone-Based App to Improve Adjuvant Treatment Adherence to Multidisciplinary Decisions in Patients With Early-Stage Breast Cancer: Observational Study

Journal of medical Internet research, 2021-09, Vol.23 (9), p.e27576-e27576

2021

Volltextzugriff (PDF)

Biological Roles and Clinical Applications of Exosomes in Breast Cancer: A Brief Review

International journal of molecular sciences, 2024-05, Vol.25 (9), p.4620

2024

Volltextzugriff (PDF)

Nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysis

Oncotarget, 2017-03, Vol.8 (10), p.17360-17372

2017

Volltextzugriff (PDF)

Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer

Breast cancer (Tokyo, Japan), 2022-09, Vol.29 (5), p.844-853

2022

Volltextzugriff (PDF)

Association of serum lipid levels and clinical outcomes in early breast cancer patients

Therapeutic advances in medical oncology, 2023-01, Vol.15, p.17588359231177004-17588359231177004

2023

Volltextzugriff (PDF)

Pathological underestimation and biomarkers concordance rates in breast cancer patients diagnosed with ductal carcinoma in situ at preoperative biopsy

Scientific reports, 2022-02, Vol.12 (1), p.2169-2169, Article 2169

2022

Volltextzugriff (PDF)

Prolonged Time to Adjuvant Chemotherapy Initiation Was Associated with Worse Disease Outcome in Triple Negative Breast Cancer Patients

Scientific reports, 2020-04, Vol.10 (1), p.7029-7029, Article 7029

2020

Volltextzugriff (PDF)

Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin

Proceedings of the National Academy of Sciences - PNAS, 2020-12, Vol.117 (52), p.33295-33304

2020

Volltextzugriff (PDF)

Association of Biomarker Discrepancy and Treatment Decision, Disease Outcome in Recurrent/Metastatic Breast Cancer Patients

Frontiers in oncology, 2021-07, Vol.11, p.638619-638619

2021

Volltextzugriff (PDF)

Distribution, dynamic evolution, and clinical outcomes of patients with advanced breast cancer according to HER2 expression

BMC cancer, 2023-02, Vol.23 (1), p.173-173, Article 173

2023

Volltextzugriff (PDF)

Time interval between breast cancer diagnosis and surgery is associated with disease outcome

Scientific reports, 2023-07, Vol.13 (1), p.12091-12091, Article 12091

2023

Volltextzugriff (PDF)

Comprehensive Transcriptomic Analysis Reveals Dysregulated Competing Endogenous RNA Network in Endocrine Resistant Breast Cancer Cells

Frontiers in oncology, 2020-11, Vol.10, p.600487-600487

2020

Volltextzugriff (PDF)

The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients

Journal of breast cancer, 2024-06, Vol.27 (3), p.163

2024

Volltextzugriff (PDF)

Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study

Frontiers in oncology, 2020-12, Vol.10, p.580112-580112

2020

Volltextzugriff (PDF)

1 – 25 von 239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(209)
Mit Volltextzugriff
(221)

Publikationsform

Sprache

Englisch
(229)
Chinesisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Frontiers In Oncology
(18)
Cancer Research
(16)
Breast Cancer Research And Treatment
(13)
Bmc Cancer
(8)
Journal Of Clinical Oncology
(7)
Plos One
(7)
Oncotarget
(6)
Cancer Medicine
(5)
Chung-Hua Wai Kʿo Tsa Chih
(5)
Journal Of Cancer
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Single‐cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy

The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis

The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis

Stromal cells in tumor microenvironment and breast cancer

Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis

Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer

Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24

Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis

Comprehensive analysis of the 21-gene recurrence score in invasive ductal breast carcinoma with or without ductal carcinoma in situ component

A Smartphone-Based App to Improve Adjuvant Treatment Adherence to Multidisciplinary Decisions in Patients With Early-Stage Breast Cancer: Observational Study

Biological Roles and Clinical Applications of Exosomes in Breast Cancer: A Brief Review

Nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysis

Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer

Association of serum lipid levels and clinical outcomes in early breast cancer patients

Pathological underestimation and biomarkers concordance rates in breast cancer patients diagnosed with ductal carcinoma in situ at preoperative biopsy

Prolonged Time to Adjuvant Chemotherapy Initiation Was Associated with Worse Disease Outcome in Triple Negative Breast Cancer Patients

Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial

Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin

Association of Biomarker Discrepancy and Treatment Decision, Disease Outcome in Recurrent/Metastatic Breast Cancer Patients

Distribution, dynamic evolution, and clinical outcomes of patients with advanced breast cancer according to HER2 expression

Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial

Time interval between breast cancer diagnosis and surgery is associated with disease outcome

Comprehensive Transcriptomic Analysis Reveals Dysregulated Competing Endogenous RNA Network in Endocrine Resistant Breast Cancer Cells

The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients

Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study

Suchergebnisse filtern